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Abstract
Cardiovascular fibrosis resulted from pressure overload or ischemia could alter myocardial stiffness and lead to ventricular
dysfunction. Fluorescently labeled collagen-binding protein CNA 35, derived from the surface component of Staphylococcus
aureus, and a novel synthetic biphenylalanine containing peptide are applied to stain fibrosis associated collagen and
myocytes, respectively. Detailed pathological characteristics of cardiovascular fibrosis could be identified clearly in 2 hours.
This staining pair requires only simple staining and brief washing, generating less than 10 ml of waste. The image
information collected by this novel fluorescent staining pair is compatible with it collected by the traditional Masson’s
Trichrome and Picrosirius Red staining which are widely used to stain cardiovascular fibrosis and isolated cells.
Citation: Chen J, Lee SK, Abd-Elgaliel WR, Liang L, Galende E-Y, et al. (2011) Assessment of Cardiovascular Fibrosis Using Novel Fluorescent Probes. PLoS ONE 6(4):
e19097. doi:10.1371/journal.pone.0019097
Editor: Christian Schulz, Heart Center Munich, Germany
Received December 17, 2010; Accepted March 16, 2011; Published April 20, 2011
Copyright:  2011 Chen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by grants from the National Institutes of Health R01HL088434, R01HL093183, P20HL100396 (RJH), CA135312 (CHT),
and the Transatlantic Leducq Foundation (RJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Roger.hajjar@mssm.edu (RJH); ctung@tmhs.org (CHT)
. These authors contributed equally to this work.
Introduction
Fibrosis in the heart is associated with many cardiac diseases,
such as hypertrophy and coronary ischemic heart disease.[1,2] To
assess the dynamic status of fibrosis, which is an alternation of
myocardial collagen network, proper reagents that recognize
collagen fibers in vitro and in vivo would be extremely valuable in
understanding the definitive mechanism of hypertrophy and heart
failure. Currently histological analysis of heart tissues is the most
accepted and sensitive way to study pathological changes of
fibrosis. Masson’s Trichrome and Picrosirius Red are two
commonly used collagen staining methods for cardiovascular
fibrosis detection.[3,4] They provide clear contrast to distinguish
collegens from surrounding connective tissue and cells. Although
these methods are excellent in examining collagen density and
structure, the procedure is lengthy and consumes large amount of
reagents and washing solutions. Cleaner and more efficient
histopathological stains, which could offer compatible histological
details while conserving reagents, resource and time, would
certainly be a favorable choice.
Recently we have found two new probes which are suitable for
pathological analysis of fibrotic tissues. The first probe, termed
CNA35, is derived from the collagen binding microbial surface
components recognizing adhesive matrix molecules (MSCRAMM)
on Staphylococcus aureus.[5] The original CNA protein is composed
of two subdomains (N1 and N2), each adopting an IgG-like fold.
According to recently reported crystal structure of N1N2 segment
of CNA, it forms a complex with synthetic collagen-like triple
helical peptide.[6] CNA35, a truncated form of CNA with a
higher affinity than the wild type protein, has been used as a tissue
staining probe based on its specific binding property to collagen
fibers, including collagen type I, III and IV.[7] In animal studies,
CNA35 has recently been applied to label collagen of atheroscle-
rotic arteries in healthy and apolipoprotein E
2/2 mice.[8,9,10]
The second probe, termed myocyte targeting peptide (MTP)
probe, is a short synthetic peptide which contains three
biphenylalanine (Bip) unusual amino acid residues (Figure 1). Its
excellent selectivity for myocyte was discovered serendipitously
during the development of collagen binding probes.
In present study, we demonstrated the usage of CNA35 and
MTP probes in assessing myocardial fibrosis induced by aortic
constriction following coronary arterial occlusion and aorta de-
banding. Comparing with Masson’s Trichrome and Picrosirius
Red, this ‘‘green’’ staining pair presents significant advantages in
staining excised tissues and isolated cells, while offering
compatible staining with little amount of agents and in a short
period of time.
Results
Tissue preparation and general staining procedures
After 5 minutes fixation with 50% methanol + 50% acetone, the
CNA35/MTP staining could be conveniently done on OCT
samples with a 60-min incubation at room temperature and
followed by three simple washes, all by pipetting small amount of
reagents and buffers. The overall procedure for probe staining
took about 2 hours, and the total volume of waste is less than
10 ml; while the conventional Masson’s Trichrome and Picrosirius
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few more steps of staining and washing.
Comparing with conventional Picrosirius Red and
Masson’s Trichrome staining in histological sections
After Masson’s Trichrome staining, distinct blue collagen fibers
and red myocytes were observed in the tissues collected from
hypertrophic hearts. (Figure 2A and B). Similarly, Picrosirius Red
staining (Figure 2C) was able to demonstrate the fibrosis and
nucleus in myocytes nicely. CNA35 fluorescent staining also
highlighted interstitial fibrosis with similar quality (Figure 2D).
With a counterstain of myocyte with FITC labeled MTP, the
structure of collagens was clear.
The networked collagens are usually strong in vessel stress, but
their local tissue density is relatively low. After fixing by Bouin’s
solution (containing 10% formalin) during Masson’s Trichrome
staining, the perivascular tissue became shrunken, resulting in
obvious defects (empty spots) in the perivascular space (Figure 3A).
When tissue sections were fixed with 50% methanol + 50%
acetone, CNA35 monochrome staining showed more intact
collagen fibers compared with Masson’s Trichrome staining
(Figure 3B). Although the vessel borders were difficult to define
by CNA35 staining alone, MTP was able to clearly stain myocytes
and thickened arterial wall, offering a useful counterstain
(Figure 3C). Therefore, dual staining with CNA35 and MTP
provided excellent delineation of perivascular fibrosis and vascular
wall (Figure 3D).
Neointima resulted from aortic banding plus ischemia/reperfu-
sion followed by aortic de-banding (Ab+I/R+DeAb) was shown by
Picrosirius Red staining (Figure 4A) and Masson’s Trichrome
(Figure 4B) stain, respectively. In comparison, greater detail of the
neointimal components could be seen using CNA35/MTP double
labeling. Figure 4C shows MTP mono-staining and Figure 4D
shows fibrillar matrix under collagens by dual staining. Similar
Figure 1. Chemical structure of MTP.
doi:10.1371/journal.pone.0019097.g001
Figure 2. Interstitial fibrosis in hypertrophic hearts. A. normal control heart and B. hypertrophic heart with Masson’s Trichrome stain. Blue =
fibrous collagen, red = myocytes, black = nuclei, C: Picrosirius Red stain on hypertrophic heart, red = fibrous collagen, pale yellow = myocytes,
black = nuclei. D: CNA35-Cy3 (red) and MTP-FITC (green) double stain on hypertrophic heart.
doi:10.1371/journal.pone.0019097.g002
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Masson’s Trichrome staining was good for general slide staining
(Figure 5A and 5B), and Picrosirius Red was excellent in showing
cellular nuclei (Figure 5C). Complex collagen network in the area
after myocardial infarction was probed clearly by CNA35
(Figure 5D). These dual florescent images suggested that the
CNA35/MTP double labeling kit could offer greater detail of
tissue architecture in a region of fibrosis.
Figure 3. Perivascular fibrosis staining. A: Masson’s Trichrome staining. B: CNA35 mono staining for collagen fibers. C: MTP mono staining for
myocyte. D: Double staining for collagen (CNA35-Cy3, red) and myocyte (MTP-FITC, green).
doi:10.1371/journal.pone.0019097.g003
Figure 4. Staining of neointima in coronary arteries in Ab+I/R+DeAb heart in rats. A: Picrosirius Red staining. B: Masson’s Trichrome. C:
CNA35 mono staining. D: Double staining for collagen (CNA35-Cy3, red) and myocyte (MTP-FITC, green).
doi:10.1371/journal.pone.0019097.g004
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To furtherexploretheirpotential applications, CNA35 and MTP
fluorescent probes were tested on freshly isolated myocytes and
fibers. Without staining, it is difficult to define collagen fibers from
dead cells under bright-field microscopy (Figure 6A). Hematoxylin
and eosin staining was likewise limited (Figure 6B). However,
Figure 5. Staining of fibrosis in infarcted area. A and B: Masson’s Trichrome, C: Picrosirius Red staining. D: Double staining for collagen (CNA35-
Cy3, red) and myocyte (MTP-FITC, green).
doi:10.1371/journal.pone.0019097.g005
Figure 6. Images of isolated myocytes and fibers. A: Bright-field image of myocytes without staining. B: Bright-field image of myocytes with H-
E staining. C: Double staining for collagen (CNA35-Cy3, red) and myocyte (MTP-FITC, green). Florescent probe could distinguish fibers from alive and
dying (round) myocytes. D: Enlarged myocytes labeled with MTP-FITC. Blue is DAPI for nuclei.
doi:10.1371/journal.pone.0019097.g006
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fibers (Figure 6C, red), dying cells (Figure 6C, green, round) and live
myocytes (Figure 6C and 6D, green, rod cells).
Discussion
The myocardium is an elastic network of myocytes enmeshed in
a collagen matrix that connects the myocytes and supporting
coronary vasculature. The adaptive remodeling process consists of
a range of changes in tissue architecture, which include
cardiovascular fibrosis, vessel wall thickening, endothelial dysfunc-
tion and myocyte hypertrophy.[11] The response of individual
myocardial components is influenced by both hemodynamic and
nonhemodynamic factors.[12,13,14] Fibrosis is initially a repara-
tive response to high blood pressure or myocardial infarction.[11]
It is important to have an effective and rapid technique to assess
dynamic fibrosis in the infarcted scar and remote myocardium.
CNA35, a small protein extracted from the collagen-binding
domain of Staphylococcus aureus, preserves the high collagen binding
specificity and affinity.[5] Recently CNA35 with a fluorescent tag
has been applied to visualize collagen not only in tissue and live
cell culture, but also in an animal atherosclerosis mod-
el.[7,8,10,15] In conjunction with MTP, a new myocyte staining
agent, we confirmed that CNA35/MTP is an excellent pair in
probing cardiovascular fibrosis on heart tissue slides and isolated
cardiac collagen fibers.
CNA35/MTP staining is a simple and fast technique which uses
frozen sections, produces very little (10 ml) potential hazardous
waste and can be completed in less than 2 hours. This staining
protocol is compatible with traditional Masson’s Trichrome and
Picrosirius Red stainings which are often used to measure
cardiovascular fibrosis. If Picrosirius Red or Masson’s Trichrome
stain was performed on frozen OCT-embedded sections, the
whole procedure also takes about 2 hours. Whereas, if paraffin
sections were used, the staining procedures, including deparaffi-
nization, rehydration and dehydration, produce more than 1 liter
of highly hazardous, carcinogenic chemicals (including formalde-
hyde, picric acid, and hematoxylin) and more than 10 liters of
diluted toxic aqueous waste due to extensive washing, and take
more than 6 hours to complete.
Pathophysiology of isolated myocytes has been studied for
decades,[16,17] while isolated cardiac collagen fibers has yet to be
investigated. Upon isolation, collagen fibers and dead myocytes
could not be distinguished easily in vitro under a regular
microscope. Our staining presents a promising way to study the
elastic characteristics of viable cardiovascular fiber bundles in vitro.
We have also demonstrated the superb myocyte selectivity of the
MTP probe in both tissues section and live cells. It is not clear how
MTP probe could selectively bind to myocyte with such high
affinity, but this selectivity appears to be Bip dependent (data not
shown). Our preliminary experiments showed that MTP peptides
with fewer Bip had much less affinity to myocytes. More studies
are in progress to understand this distinct binding selectivity.
In this study, FITC and Cy3 were used as the fluorescent
reporters. Many more commercially available fluorochromes with
different optical properties could be selected according to the
needs. Furthermore, these two probes could be used conveniently
in conjunction with other fluorescently labeled antibodies to assess
the interactions between collagen fibers, myocytes, vessel endo-
thelium and other pathologically relevant structures or molecules.
Although histological staining could provide details tissue
information, it still relies on ex vivo analysis on collected tissues.
If an imaging technology could provide similar information non-
invasively, it will be extremely useful in clinical diagnosis.
Currently we are in the process of labeling CNA35 and MTP
with imaging reporters, and then will try to image cardiovascular
fibrosis using animal models.
In conclusion, CNA35 and MTP are new and promising
fluorescent probes in the assessment of cardiovascular fibrosis.
CNA35/MTP double-staining is a simple and fast method with
minimal environmental toxic waste to enable co-labeling of
collagen fibers and myocytes in hypertrophy and coronary
ischemic disease in vitro.
Materials and Methods
Collagen binding CNA35 probe
Recombinant CNA35 protein was a kind gift from Dr. Magnus
Hook (Texas A&M University, USA). CNA35 (1 mg) in sodium
carbonate-sodium bicarbonate buffer (1 ml) was reacted with Cy3
monofunctional reactive dye (GE Healthcare, Piscataway, NJ,
USA) for 30 min at room temperature. Cy3-labelled CNA35
(CNA35-Cy3) were purified by gel permeation chromatography
after pre-equilibrating the sephadex G25 (GE Healthcare) column
with phosphate-buffered saline. The final concentration and
degree of labeling were determined by measuring the absorbance
spectrum of the labeled protein by UV-visible spectrophotometer
(Varian, Palo Alto, CA, USA). On average, CNA35-Cy3 tagged
ratio was 0.8.
Biphenylalanine Myocyte targeting peptide (MTP) probe
FITC bAla-Gly-Gly-Lys(Bip)-Gly-Gly-Lys(Bip)-Gly-Gly-Bip-
NH2 was synthesized by solid-phase peptide synthesis on an
automatic synthesizer (ABI-433A, Applied Biosystems, Carlsbad,
CA, USA). Briefly, the C-terminal Bip (Synthetech, Albany, OR,
USA) was directly attached to resin support by standard Fmoc
strategy. After elongation of the peptide chain, fluorescein 5-
isothiocyanate (FITC) was coupled to the last N-terminal amino
acid, beta alanine (bAla). For subsequent side chain modification,
the MTT protecting group of the lysine residues was selectively
removed with 1% TFA in DCM. Thereafter, Bip was coupled to
the Lys side chains using HOBt/HBTU/DIPEA (Figure 1). The
peptide was cleaved and purified through reversed phase high
performance liquid chromatography (RP-HPLC) in a linear
gradient from 0% B to 60% B (8 ml/min) in 70 minutes. The
purity and identity of the purified MTP was confirmed by LC-MS
on C-18 Vydac column, 5 mm, 4.6 mm ID6150 mm L, (GRACE,
Deerfield, IL, USA) using Accela HPLC coupled with photodiode
array detector and autosampler (ThermoFisher Scientific, West
Palm Beach, FL, USA). Fractions with the same purity ($95%)
were collected together and lyophilized to yield yellowish powders.
ESI-MS: calculated: C93H100 N16O17S=1745.95; observed:
(M+H)
+ =1746.70; (M+2H)
2+/2=873.42 and (M+3H)
3+/3=
582.66. The conjugate were stored at 4uC in the dark.
Animal Protocol
All procedures conformed to the recommendations of the Guide
for the Care and Use of Laboratory Animals (Department of
Health and Human Services publication number NIH 78–23,
1996) and were approved by the Mount Sinai School of Medicine
Animal Care and Use Committee. Sprague Dawley male rats
(200 g) underwent aortic constriction for four months to induce
hypertrophy and interstitial and perivascular fibrosis. The
ascending aorta was banded (Ab) with a 4-0 suture against a PE-
50 tube (outside diameter =0.96 mm) through right thoracotomy
at the second intercostal space. In order to induce neointima in
coronary artery, two months post aortic banding, the rats
underwent LAD ligation for 30 minutes followed by reperfusion
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injury, the chest was reopened for aortic de-constriction (DeAb).
The suture around ascending aorta was cut with micro-dissection
scissors and separated with cotton tipped applicators. One month
post de-banding aorta, the hearts were harvested for experiments.
For all surgical procedures, anesthesia was induced by intraper-
itoneal administration of pentobarbital (60 mg/kg).
Histological Analysis
At end time point, hearts were perfused with 30 ml of cold PBS
with 0.1 ml of 1% heparin. LV was harvested, embedded in OCT,
frozen and stored at 280uC. OCT heart sample was sectioned at
8 mm. Masson’s Trichrome was conducted according to the
guideline of the agent kit from Sigma (HT15, St. Louis, MO,
USA). Briefly, frozen slides were fixed in Bouin’s solution. After
incubation in Weigert’s Iron Hematoxylin Solution, the slides was
stained with Biebrich Scarlet-Acid Fuchsin and Aniline Blue and
dehydrated in ethanol and xylene. Extensive washes were done
between each staining. The collagen fibers were stained blue, the
nuclei were stained black and myocardium was stained red.
Picrosirius Red staining was performed following the protocol of
the agent kit from Polysciences Inc (cat#: 24901, Warrington, PA,
USA). The collagen fibers were stained red, nuclei were blue, and
myocytes were pale yellow.
For fluorescent probe staining, frozen sections were fixed with
50% methanol + 50% acetone, blocked with 5% BSA for 30
minutes. The tissues were incubated with one or two fluorescent
probes (300 ml/slide, 10 mM solution) for 1 hour at room
temperature. After washing three times in PBS, the slides were
mounted with DAPI medium (H-1500, Vector Lab, Burlingame,
CA, USA). The FITC and Cy3 fluorescent signals were visualized
using confocal microscopy.
Isolation of myocytes and fibers
Rat heart was retrogradely perfused for 5 minutes with
oxygenated Krebs-Henseleit buffer at 37uC. The heart was
digested by collagenase (type II, Worthington Lakewood, NJ,
USA) and hyaluronidase (type II, Sigma).[19] The digestion
solution was filtered through a 150-mm steel mesh. Cells were
incubated with fluorescent probes (1:100) and DAPI (1.5 mg/ml)
for 30 minutes. The FITC and Cy3 fluorescent signals were
visualized using confocal microscopy.
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